БЛОГ

Archive for the ‘biotech/medical’ category: Page 1643

Apr 6, 2020

Ancient tooth proteins reveal our relation to mysterious human species

Posted by in categories: biotech/medical, evolution

It’s hard to piece together the full history of human evolution from piles of old bones. But now, scientists have made use of a new method to study proteins in dental enamel of an 800,000-year-old human species, helping place it in the family tree.

Although Homo sapiens is the only human species still alive today, the road to get here is paved with extinct relatives. And untangling how they’re all related to each other is a task that scientists continue to wrestle with. The timeline is usually determined through various dating processes, both on the bones themselves and the sediment layers they’re found in. Relationships between species are then determined from this timeline, and by examining the structures and features of the bones to track the progress of evolution.

For the new study, researchers at the University of Copenhagen have used a new tool called palaeoproteomics to get a more precise picture. This involves sequencing proteins from ancient remains, and it works on samples that are far too old to have intact DNA. In this case, the team applied it to the 800,000-year-old teeth of a mysterious, archaic human species called Homo antecessor.

Apr 6, 2020

Liz Parrish about Anti-Aging gene therapy

Posted by in categories: biotech/medical, life extension

Liz Parrish is the Founder and CEO of BioViva Sciences USA Inc.
https://www.youtube.com/channel/UCaBq8hEExcUN6

You can support me:
PayPal: [email protected]
Gpay: [email protected]
Patreon: https://www.patreon.com/user?u=27929324

Apr 5, 2020

Why do some young people die of coronavirus?

Posted by in category: biotech/medical

Covid-19 hits the old hardest, but young people are dying too. Scientists say it may be down to genes or ‘viral load’.

Apr 5, 2020

Real life ‘shrink ray’ can reduce 3D structures

Posted by in categories: biotech/medical, quantum physics

Could used for anything to reduce size just like an ant man suit :3.


Scientists can put all kinds of useful materials in the polymer before they shrink it such as metals, quantum dots and DNA. Pictured is the machine used to shrink objects.

The polyacrylate forms the scaffold over which other materials can be attached.

Continue reading “Real life ‘shrink ray’ can reduce 3D structures” »

Apr 5, 2020

HIV drug showing signs of successfully treating coronavirus patients

Posted by in category: biotech/medical

A drug used to treat HIV and cancer patients has shown success in treating some of the most severe coronavirus patients and was just cleared by the U.S. Food and Drug Administration to start a phase two clinical trial. Much of the work behind the drug is happening in Washington state.

Apr 5, 2020

ENDING SMOKING In This Generation

Posted by in categories: biotech/medical, economics, food, law, life extension, policy

Dr. Derek Yach, Founder, President, and Board Member of The Foundation for a Smoke-Free World (FSFW), joined me on ideaXme (http://radioideaxme.com/) to discuss his group’s work in the core areas of Agriculture and Livelihoods, Industry Transformation, and Health, Science, and Technology (Disclosure — FSFW is funded ~$US1 Billion by Philip Morris International, but take a listen to full story…) — #Ideaxme #Smoking #Vaping #Tobacco #Cessation #AlternativeUses #HarmReduction #WHO #CDC #Health #Wellness #Longevity #Biotechnology #LifeExtension #Aging #IraPastor #Bioquark #Regenerage World Health Organization (WHO) CDC CDC Global United Nations Philip Morris International.


Ira Pastor, ideaXme life sciences ambassador and founder of Bioquark, interviews Dr. Derek Yach, founder, president, and board member of The Foundation for a Smoke-Free World, and passionate advocate for health promotion and disease prevention. Dr Yach’s objective is to end smoking in this generation. We investigated to see how that might be achieved.

Continue reading “ENDING SMOKING In This Generation” »

Apr 5, 2020

Creating Superman (and woman): Who benefits from human enhancement?

Posted by in categories: biotech/medical, cyborgs, genetics, life extension, nanotechnology, neuroscience, transhumanism

Research involving bowhead whales has suggested that it may one day be possible to extend the human lifespan to 200 years.


From the demigods of Greek mythology to the superheroes of 20th century comic books, we’ve been intrigued by the idea of human enhancement for quite a while, but we’ve also worried about negative consequences. Both in the Greek myths and modern comics and television, each enhanced human has been flawed in some way.

Continue reading “Creating Superman (and woman): Who benefits from human enhancement?” »

Apr 5, 2020

The 47th State Panacea or Perversion

Posted by in categories: biotech/medical, sustainability

We have the technology to potentially add a 47th chromosome, to compound as it were, a new human entity. The implications are enormously consequential.


C.S. Lewis warned about our final mastery over nature, and the inevitable drift into a future world where knowledge about the old world completely vanishes, where what once was, irretrievably transforms into something else:

Continue reading “The 47th State Panacea or Perversion” »

Apr 5, 2020

COVID-19 vaccine candidate shows promise

Posted by in category: biotech/medical

Researchers at University of Pittsburgh School of Medicine report the creation of a promising COVID-19 vaccine candidate – named PittCoVacc – and are hoping for a fast approval track, lasting less than the usual year of testing, by the U.S. Food and Drug Administration (FDA).

Apr 5, 2020

A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

Posted by in category: biotech/medical

:oooo.


Precision oncology relies on accurate discovery and interpretation of genomic variants, enabling individualized diagnosis, prognosis and therapy selection. We found that six prominent somatic cancer variant knowledgebases were highly disparate in content, structure and supporting primary literature, impeding consensus when evaluating variants and their relevance in a clinical setting. We developed a framework for harmonizing variant interpretations to produce a meta-knowledgebase of 12,856 aggregate interpretations. We demonstrated large gains in overlap between resources across variants, diseases and drugs as a result of this harmonization. We subsequently demonstrated improved matching between a patient cohort and harmonized interpretations of potential clinical significance, observing an increase from an average of 33% per individual knowledgebase to 57% in aggregate. Our analyses illuminate the need for open, interoperable sharing of variant interpretation data. We also provide a freely available web interface (search.cancervariants.org) for exploring the harmonized interpretations from these six knowledgebases.